Rajna Golubic, a member of Mark Evans’ group, has been announced as the overall winner of the Royal College of Physicians 2021 Turner-Warwick lecturer scheme. Ranja will present a lecture entitled ‘Novel treatments to improve metabolic health in obesity and type 2 diabetes: the effects of cotadutide, a dual GLP1-glucagon receptor agonist, on energy balance’ as […]
The artificial pancreas can help protect very young children with Type 1 Diabetes
Members of the Hovorka Group teamed with an international team of researchers have compared the performance, in children, of the artificial pancreas against ‘sensor-augmented pump therapy’. The artificial pancreas uses an algorithm run by a mobile phone app (CamAPS FX) to automate delivery of insulin according to need. They found that it is both safe […]
New study reveals sex-specific effects of obesity during pregnancy
Researchers in the Ozanne group have described the effects of maternal diet-induced obesity on lipid composition in maternal and fetal serum and the fetal heart, and in the fetal heart transcriptome. The study published in eLife, revealed sex-specific effects of obesity during pregnancy, possibly contributing to the previously observed changes in heart function in adult […]
Daybreak trial in genetic causes of obesity
The research team at GOOS led by Professor Sadaf Farooqi are excited to announce that they have started treating patients with several different genetic conditions which cause obesity, with Setmelanotide, a melanocortin-4 receptor (MC4R) agonist. Following successful trials in three genetic obesity syndromes (POMC, PCSK1, LEPR), this new trial called ‘DAYBREAK’, will test whether Setmelanotide […]
- 1
- 2
- 3
- …
- 28
- Next Page »
